The following pages link to Informative Dorfman screening (Q2894021):
Displaying 27 items.
- Array-based schemes for group screening with test errors which incorporate a concentration effect (Q897626) (← links)
- Group testing case identification with biomarker information (Q1662329) (← links)
- Determination of varying group sizes for pooling procedure (Q2003657) (← links)
- Statistical modeling for practical pooled testing during the COVID-19 pandemic (Q2143947) (← links)
- Robust procedures for experimental design in group testing considering misclassification (Q2348315) (← links)
- Reader reaction: A note on the evaluation of group testing algorithms in the presence of misclassification (Q2805225) (← links)
- The optimal group size using inverse binomial group testing considering misclassification (Q2816441) (← links)
- Sequential estimation in the group testing problem (Q4639214) (← links)
- Group testing: Revisiting the ideas (Q4993846) (← links)
- Optimal Genetic Screening for Cystic Fibrosis (Q5031012) (← links)
- Optimal Screening of Populations with Heterogeneous Risk Profiles Under the Availability of Multiple Tests (Q5084639) (← links)
- Static Risk-Based Group Testing Schemes Under Imperfectly Observable Risk (Q5141708) (← links)
- Optimal Group Testing: Structural Properties and Robust Solutions, with Application to Public Health Screening (Q5148172) (← links)
- Two‐Stage Hierarchical Group Testing for Multiple Infections with Application to the Infertility Prevention Project (Q5408030) (← links)
- Revisiting Nested Group Testing Procedures: New Results, Comparisons, and Robustness (Q5868171) (← links)
- A Note on the Minimax Solution for the Two-Stage Group Testing Problem (Q5885349) (← links)
- Screening multi‐dimensional heterogeneous populations for infectious diseases under scarce testing resources, with application to <scp>COVID</scp>‐19 (Q6053041) (← links)
- Nested group testing procedure (Q6084114) (← links)
- groupTesting: an R package for group testing estimation (Q6125015) (← links)
- Optimal targeted mass screening in non‐uniform populations with multiple tests and schemes (Q6150228) (← links)
- Flexible, efficient, and accurate tests for epidemics (Q6595570) (← links)
- Optimal Dorfman group testing for symmetric distributions (Q6617267) (← links)
- How could a pooled testing policy have performed in managing the early stages of the COVID-19 pandemic? Results from a simulation study (Q6618511) (← links)
- Is group testing ready for prime-time in disease identification? (Q6628407) (← links)
- Discussion on: ``Is group testing ready for prime-time in disease identification?'' (Q6628408) (← links)
- Regression analysis and variable selection for two-stage multiple-infection group testing data (Q6628713) (← links)
- The objective function controversy for group testing: much ado about nothing? (Q6628751) (← links)
